InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Bass and Spangenberg file sixth IPR petition, targeting Pharmacyclics

Michael Loney, New York


The Coalition for Affordable Drugs has filed another inter partes review petition at the Patent Trial and Appeal Board, in the latest move by Kyle Bass and Erich Spangenberg to target pharmaceutical companies’ patents

The IPR petition challenges claims of US patent 8754090, which is owned by Pharmacyclics. AbbVie announced a deal to buy Pharmacyclics in a $21 billion deal in  March. The patent is for the cancer drug Imbruvica and covers methods for...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog


null null null

nullnullnull

null

May / June 2019

From trademarks to trade secrets: in-house tips on brand protection in China

Despite the well-known struggles in protecting trademarks and trade secrets in China, there are some tried-and-tested strategies to employ, as Karry Lai and Ellie Mertens hear from in-house counsel at a range of domestic and international companies



Most read articles

Supplements